Gyre Therapeutics, Inc.

GYRE·NASDAQ·$5.94Share Price as of 11/2·$576MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/07/26 10-QQ1 ended 03/31/2605/08/26 10-KFY 202503/13/26 10-QQ3 ended 09/30/2511/07/25 10-QQ2 ended 06/30/2508/11/25

Disclosures

8-KCurrent report10/22/26 8-KCurrent report09/01/26 8-KCurrent report08/26/26 8-KCurrent report08/07/26 8-KCurrent report07/16/26

Prospectuses and Registrations

S-8Registration of securities for employees08/31/26 S-3/AShelf registration (amended)07/13/26 S-3Shelf registration06/23/26 S-8Registration of securities for employees06/10/26 424B5Prospectus supplement05/23/25

Proxies

DEFA14AAdditional proxy materials05/04/26 DEF 14ADefinitive proxy04/27/26 DEFA14AAdditional proxy materials04/27/26 PRE 14APreliminary proxy04/16/26 DEF 14ADefinitive proxy04/21/25

Ownership

Form 3Initial insider ownership08/04/26 Form 3Initial insider ownership08/04/26 Form 4Insider transaction08/04/26 Form 4Insider transaction08/04/26 Form 4Insider transaction06/30/26

Other

EFFECTRequest for effectiveness08/03/26 ARSAnnual report to shareholders04/27/26 ARSAnnual report to shareholders04/22/25 EFFECTRequest for effectiveness11/22/24 CORRESPCorrespondence with the SEC11/20/24